Latest Articles

Publication Date
Antibody therapy points to a new treatment era for primary membranous nephropathy - drugdiscoverynews.com

Antibody therapy points to a new treatment era for primary membranous nephropathy drugdiscoverynews.com

Published: June 16, 2026, 9:19 p.m.
Depo Provera Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center

Depo Provera Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center

Published: June 16, 2026, 1:01 p.m.
Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment - EMJ

Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis: Burden, Mechanism, and Implications for Treatment EMJ

Published: June 16, 2026, 9:15 a.m.
Managing Endometriosis-Associated Pain: A Two-Step Approach - EMJ

Managing Endometriosis-Associated Pain: A Two-Step Approach EMJ

Published: June 16, 2026, 6:33 a.m.
Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." - La Milano

Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." La Milano

Published: June 16, 2026, 5:13 a.m.
Natural Cycle FET vs Artificial Cycle: Live Birth Rates - OC Academy

Natural Cycle FET vs Artificial Cycle: Live Birth Rates OC Academy

Published: June 12, 2026, 5:42 a.m.
Endometriosis is a Silent Emergency with Eleanor Thom - BBC

Endometriosis is a Silent Emergency with Eleanor Thom BBC

Published: June 12, 2026, 5:15 a.m.
Massive Hoover Dam flag removed just weeks before America's 250th anniversary - newscentermaine.com

Massive Hoover Dam flag removed just weeks before America's 250th anniversary newscentermaine.com

Published: June 11, 2026, 6:49 p.m.
ESGN intensifies endometriosis awareness as winners emerge in 10th essay competition - Punch Newspapers

ESGN intensifies endometriosis awareness as winners emerge in 10th essay competition Punch Newspapers

Published: June 11, 2026, 4:22 p.m.
Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates - marketscreener.com

Medicus Pharma Submits Ind Application for PRECISION-E2 Phase 2A Study of Teverelix in Endometriosis in United Arab Emirates marketscreener.com

Published: June 11, 2026, 1:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!